SINGLE NUCLEOTIDE POLYMORPHISM IN CYTOKINES AND RISK OF HEPATOCELLULAR CARCINOMA IN EGYPTIAN PATIENTS

HEBA ABDEL-AZYEM, AMAL ABDEL-AZIZ, R. ELBAZ, A. ELDESOKY, W. S. ABDEL-MAGEED

Abstract


Polymorphisms in cytokine genes responsible for inflammatory and immune responses are associated with risk of hepatocellular carcinoma (HCC) in Egyptian population. HCC study had conducted on 75 HCC patients and 75 matched control subjects of Egyptian population. Genetic variants in the IL-101082, TNF-α308 and IL-1β511 genes were analyzed by SNP. The logistic regression method was used to analyze the data, relative to the putative high-activity genotypes; individual low-activity genotypes were associated with statistically non-significant increases in HCC risk. The genotypic frequencies in the cases were not similar to that of the controls, TNF-α308 differences being statistically significant (P = 0.001). Using the GG genotype as the reference genotype, AA was significantly associated with increased risk of HCC (adjusted OR = 7.034, 95% CI, 2 = 54.399). Furthermore, we found A allele was significantly associated with increased risk of HCC, compared with G allele (2 = 53.034, OR-95% CI = 0.134 - 7.469). No such significant difference was found for cytokines (IL-1β and IL-10). Conclusion: Our study showed that TNF-α−308 G > A polymorphism was associated with increased HCC risk in Egypt population

Full Text:

PDF

References


Abbas, Z., T. Moatter, A. Hussainy and W. Jafr (2005). Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3. World J. Gastroenterol, 11: 6656-6661.

Akkiz, H., S. Bayram, A. Bekar, E. Akgöllü, B. Ozdil, A. T. Sümbül H. Demiryürek and F. Doran (2009). G-308A TNF- polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study. Cancer Epidemiol., 33: 261-264.

Bei, C. H., H. Bai, H. P. Yu, Y. Yang, Q. Q. Liang, Y. Y. Deng, S. K. Tan and X. Q. Qiu (2014). Combined effects of six cytokine gene polymorphisms and SNP-SNP interactions on hepatocellular carcinoma risk in Southern Guangxi, China. Asian Pac. J. Cancer Prev., 15: 6961-6967.

Ben-Ari, Z., O. Pappo, T. Druzd, J. Sulkes, T. Klein, Z. Samra, R. Gadba, Anat R. Tambur, R. Tur-Kaspa and E. Mor (2004). Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver trans-plantation. Cytokine, 27: 7-14.

Bidwell, J., L. Keen, G. Gallagher, R. Kimberly, T. Huizinga, M. F. McDermott, J. Oksenberg, J. McNicholl, F. Pociot, C. Hardt and S. D'Alfonso. (1999). Cytokine gene polymorphism in human disease: online databases. Genes Immun., 1: 3-19.

Bortolami, M., C. Venturi, L. Giacomelli, R. Scalerta, S. Bacchetti, F. Marino, A. Floreani, M. Lise, R. Naccarato and F. Farinati. (2002). Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer. Dig. Liver Dis., 34: 794-801.

Bunnapradist, S. and S. C. Jordan (2000). The role of cytokines and cytokine gene polymorphism in T-cell activation and allograft rejection. Ann. Acad. Med. Singapore, 29: 412-416.

Critelli, R. M., N. De Maria and E. Villa (2015). Biology of Hepatocellular Carcinoma. Dig. Dis., 33: 635-641.

De Ponti, A., L. Wiechert, D. Schneller, T. Pusterla, T. Longerich, N. Hogg, A. Vogel, P. Schirmacher, J. Hess and P. Angel (2015). A pro-tumorigenic function of S100A8/A9 in carcinogen-induced hepatocellular carcinoma. Cancer Lett., 28: 396-404.

Douglas, W. G., Y. Wang, J. F. Gibbs, E. Tracy, B. Kuvshinoff, K. Huntoon and H. Baumann (2008). Proinflammatory cytokines increase hepatocellular carcinoma cells thermotolerance: evidence of how local inflammation may negatively impact radiofrequency ablation local control rates. J. Surg. Res., 150: 118-124.

Galun, D., D. Basaric, M. Zuvela, P. Bulajic, A. Bogdanovic, N. Bidzic and M. Milicevic (2015). Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World J. Hepatol., 7: 2274-2291.

Hamza, A. H., H. M. Abdulfattah, R. H. Mahmoud, W. K. Khalil and H. H. Ahmed (2015). Current concepts in pathophysiology and management of hepatocellular carcinoma. Acta Biochim. Pol., 62: 573-580.

He, Y. and C. H. Hu (2001). Level change of IL-10, IL-12 and TNF-  in the serun of patients with hepatocellular carcinoma. Hunan Yi Ke Da Xue Xue Bao, 26: 57-58.

Heneghan, M. A., P. J. Johnson, M. Clare, S. Ho, P. M. Harrison and P. T. Donaldson (2003). Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese. Int. J. Gastrointest Cancer, 34: 19-26.

Hirankarn, N., I. Kimkong, P. Kummee, P. Tangkijvanich and Y. Poovorawan (2006). Interleukin-1 gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World J. Gastroenterol., 12: 776-779.

Hiroki, C. H., M. K. Amarante, D. L. Petenuci, A. Y. Sakaguchi, F. C. Trigo, M. A. Watanabe and C. E. de Oliveira (2015). IL-10 gene polymorphism and influence of chemotherapy on cytokine plasma levels in childhood acute lymphoblastic leukemia patients: IL-10 polymorphism and plasma levels in leukemia patients. Blood Cells Mol. Dis., 55: 168-172.

Hoffmann, S. C., E. M. Stanley, E. D. Cox, B. S. DiMercurio, D. E. Koziol, D. M. Harlan, A. D. Kirk and P. J. Blair (2002). Ethnicity greatly influences cytokine gene polymorphism distribution. Am. J. Transplant, 2: 560-567.

Huang, Y. S., S. J. Hwang, C. Y. Chan, J. C. Wu, Y. Chao, F. Y. Chang and S. D. Lee (1999). Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study. Zhonghua Yi Xue Za Zhi (Taipei), 62: 327-333.

Kato, M., S. Hazama, K. Sakamoto, S. Yoshino, A. Tangoku and M. Oka (2003). Significance of intracellular cytokines levels in peripheral lymphocytes for evaluation of surgical stress after hepatectomy in patients with hepatocellular carcinoma. Gan To Kagaku Ryoho, 30: 1848-1850.

Keen, L. J. (2002). The extent and analysis of cytokine and cytokine receptor gene polymorphism. Transpl. Immunol., 10: 143-146.

Kikodze, N., K. Mazmishvili, M. Iobadze, Kh. Rekhviashvili, N. Nanava, I. Pantsulaia, M. Mizandari, N. Janikashvili and T. Chikovani (2015). Hepatocellular carcinoma: current and prospective immunotherapeutic strategies. Georgian Med. News, 246: 78-84.

Kockar, F., H. Yildrim, R. I. Sagkan, C. Hagemann, Y. Soysal, J. Anacker, A. A. Hamza, D. Vordermark, M. Flentje and H. M. Said (2012). Hypoxia and cytokines regulate carbonic anhydrase 9 expression in hepatocellular carcinoma cells in vitro. World J. Clin. Oncol., 3: 82-91.

Lertwittayapon, T., T. Tencomnao and R. Santiyanont (2012). Inhibitory effect of alternatively spliced RAGEv1 on the expression of NF-kB and TNF- in hepatocellular carcinoma cells. Genet. Mol. Res., 11: 1712-1720.

Liu, B., Z. Yao, K. Hu, H. Huang, S. Xu, Q. Wang, Y. Yang and J. Ren (2015). ShRNA-mediated silencing of the Ndc80 gene suppress cell proliferation and affected hepatitis B virus-related hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. Moran, J. M., R. A. Gonzalez-Polo, G. Soler and J. M. Fuentes (2006). TH1/TH2 cytokines: an easy model to study gene expression in immune cells. CBE Life Sci. Educ., 5: 287-295.

Nagai, H., T. Kanekawa, K. Kobayashi, T. Mukozu, D. Matsui, T. Matsui, M. Kanayama, N. Wakui, K. Momiyama, M. Shinohara, K. Ishii, Y. Igarashi and Y. Sumino (2014). Changes of cytokines in patients with liver cirrhosis and advanced hepatocellular carcinoma treated by sorafenib. Cancer Chemother Pharmacol., 73: 223-229.

Nakazaki, H. (1992). Preoperative and postoperative cytokines in patients with cancer. Cancer, 70: 709-713.

Popko, K., E. Gorska, O. Potapinska, M. Wasik, A. Stoklosa, R. Plywaczewski, M. Winiarska, D. Gorecka, P. Sliwinski, M. Popko, T. Szwed and U. Demkow (2008). Frequency of distribution of inflammatory cytokines IL-1, IL-6 and TNF- gene polymorphism in patients with obstructive sleep apnea. J. Physiol. Pharmacol., 59 Suppl., 6: 607-614.

Renzulli, M. and R. Golfieri (2015). Proposal of a new diagnostic algorithm for hepatocellular carcinoma based on the Japanese guidelines but adapted to the Western world for patients under surveillance for chronic liver disease. J. Gastroenterol Hepatol. Saleh, D. A., S. Amr, I. A. Jillson, J. H. Wang, N. Crowell and C. A. Loffredo (2015). Preventing hepatocellular carcinoma in Egypt: results of a Pilot Health Education Intervention Study. BMC Res. Notes, 8: 384.

Saran, U., B. Humar, P. Kolly and J-F. Dufour (2016). Hepatocellular Carcinoma and Lifestyles. J. Hepatol., 64: 203-214

Sato, T., Y. Asanuma, Y. Masaki, Y. Sato, Y. Hatakeyama, T. Kusano and K. Koyama (1996). Changes in tumor necrosis factor-a and interleukin-1 beta production following liver surgery on cirrhotic patients. Hepatogastroenterology 43: 1148-1153.

Yang, M. D., C. M. Hsu, W. S. Chang, T. C. Yueh, Y. L. Lai, C. L. Chuang, S. C. Wang, L. B. Jeng, H. X. Ji, C. L. Hsiao, C. N. Wu, C. W. Tsai, J. G. Chung and D. T. Bau (2015). Tumor necrosis factor- genotypes are associated with hepatocellular carcinoma risk in taiwanese males, smokers and alcohol drinkers. Anticancer Res., 35: 5417-5423.

Yang, Y., C. Luo, R. Feng and S. Bi (2011). The TNF-, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis. J. Cancer Res. Clin. Oncol., 137: 947-952.

Ye, Y. B., F. Peng, J. Y. Li, L. P. Lin, X. W. Zheng, D. Zhou, C. Li, Q. L. Li and X. W. Cai (2011). Significance of the expression of lymphocytes and cytokines infiltrating in HCC. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 27: 1056-1060.

Zekri, A. R., M. S. E. Ashour, A. Hassan, H. M Alam El-Din, Amal M. R. El-Shehaby and M. A. Abu-Shady (2005). Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression. World J. Gastroenterol., 11: 6624-6630.

Zhu, F., X. Li, Y. Jiang, H. Zhu, H. Zhang, C. Zhang, Y. Zhao and F. Luo (2015). GdCl3 suppresses the malignant potential of hepato-cellular carcinoma by inhibiting the expression of CD206 in tumorassociated macrophages. Oncol. Rep., 34: 2643-2655.

Zhu, P., D. Tan, Z. Peng, F. Liu and L. Song (2007). Polymorphism analyses of hepatitis B virus X gene in hepatocellular carcinoma patients from southern China. Acta Biochim. Biophys. Sin (Shanghai), 39: 265-272.

Zhu, Q. R., Y. L. Ge, S. Q. Gu, H. Yu, J. S. Wang, X. H. Gu, L. E. Fei and Z. Q. Dong (2005). Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chin. Med. J., (Engl) 118: 1604-1609.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Egyptian Journal of Genetics And Cytology

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.